Home » Topics » BioWorld Science

BioWorld Science
RSS

TRACON presents safety data review results for ENVASARC pivotal trial of envafolimab

Aug. 10, 2021

Allena initiates two phase II trials of its engineered urate oxidase, ALLN-346

Aug. 10, 2021

Response rate shows potential of ficlatuzumab with chemotherapy in treating AML

Aug. 9, 2021

AstraZeneca starts phase II SOLANO study of AZD-8233

Aug. 9, 2021

Initiation of phase I/II clinical trial of AK-117 in patients with AML

Aug. 9, 2021

Atridia initiates phase I study of SHR-1905

Aug. 9, 2021

Signal peptide peptidase-like 2B has a pathogenic role in Alzheimer's disease

Aug. 9, 2021

Enrollment ongoing in phase II study of USB-002 for respiratory distress due to COVID-19

Aug. 9, 2021

Antengene and MindRank AI collaborate to advance difficult-to-drug molecular targets

Aug. 9, 2021

Phase II study of ASC-40 for the treatment of acne vulgaris approved in China

Aug. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...